Progesterone Capsule
Product Images NDC 50090-6771

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 50090-6771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Figure001)

A survival-type step graph showing probability of hyperplasia over time (months) on medication, comparing Conjugated Estrogens Alone, Conjugated Estrogens plus Micronized Progesterone (cyclical), and Placebo. The x-axis indicates time up to 36 months and the total number of patients at each interval. The y-axis shows probability ranging from 0 to 1.*

FDA Label Image

Label Image (Lbl500906771)

Label for PROGESTERONE 100 mg oral capsules by A-S Medication Solutions. The label includes directions to check the dosage package insert, storage instructions to protect from excessive moisture and store between 68 to 77 degrees Fahrenheit, and a warning not to use if allergic to peanuts. The package contains 10 capsules.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure of progesterone depicted by a molecular diagram showing rings and functional groups including ketones and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.